Evelyn Partners Investment Management LLP Gilead Sciences, Inc. Transaction History
Evelyn Partners Investment Management LLP
- $3.52 Trillion
- Q3 2025
A detailed history of Evelyn Partners Investment Management LLP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 766 shares of GILD stock, worth $95,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
766
Previous 926
17.28%
Holding current value
$95,765
Previous $84.9 Million
0.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,378Shares Held
1.01BCall Options Held
10.4MPut Options Held
8.12M-
Black Rock Inc. New York, NY121MShares$15.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.9 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.39 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.65 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.77 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $157B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...